Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
The Lancet - Early Online Publication, 06/25/09
Priotto G et al. - The efficacy of NECT is non-inferior to that of eflornithine monotherapy. Since this combination treatment also presents safety advantages, is easier to administer (ie, infusion every 12 h for 7 days vs every 6 h for 14 days), and potentially protective against the emergence of resistant parasites, it is suitable for first-line use in HAT control programmes.
Related Articles
Cerebrospinal fluid B lymphocyte identification for diagnosis and follow-up in human African trypanosomiasis in the field
Tropical Medicine & International Health, 10/08/09
Relevance Score: 84%
Human African trypanosomiasis
The Lancet - Early Online Publication, 10/14/09
Relevance Score: 82%
Shifting priorities in vector biology to improve control of vector-borne disease
Tropical Medicine & International Health, 10/08/09
Relevance Score: 80%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Inotrope and vasopressor use in the emergency department
Emergency Medicine Australasia, 12/10/09
Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones
International Journal of Infectious Diseases, 12/10/09
A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs
Malaria Journal, 12/10/09
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect
Headache: The Journal of Head and Face Pain, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


